Ratings by H.C. Wainwright (Edward White)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/11/2025 | Inozyme Pharma Inc. | INZY | Maintain | Buy (Buy) |
|
Details | ||
| 4/10/2025 | Valneva SE | VALN | Maintain | Buy (Buy) |
|
Details | ||
| 4/1/2025 | SAB Biotherapeutics | SABS | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2025 | Sensei Biotherapeutics | SNSE | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2025 | Nyxoah SA | NYXH | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2025 | Bolt Biotherapeutics, Inc. | BOLT | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/26/2025 | Artiva Biotherapeutics | ARTV | Maintain | Buy (Buy) |
|
Details | ||
| 3/25/2025 | Larimar Therapeutics | LRMR | Maintain | Buy (Buy) |
|
Details | ||
| 3/14/2025 | Nyxoah SA | NYXH | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2025 | Inozyme Pharma Inc. | INZY | Maintain | Buy (Buy) |
|
Details | ||
| 3/7/2025 | Adicet Bio Inc. | ACET | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/4/2025 | TG Therapeutics | TGTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/21/2025 | Dynavax Technologies | DVAX | Maintain | Buy (Buy) |
|
Details | ||
| 2/20/2025 | Karyopharm Therapeutics | KPTI | Maintain | Buy (Buy) |
|
Details | ||
| 2/19/2025 | Valneva SE | VALN | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2025 | Valneva SE | VALN | Maintain | Buy (Buy) |
|
Details | ||
| 1/30/2025 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 1/16/2025 | Inflarx NV | IFRX | Maintain | Buy (Buy) |
|
Details | ||
| 1/15/2025 | Karyopharm Therapeutics | KPTI | Maintain | Buy (Buy) |
|
Details | ||
| 1/15/2025 | TG Therapeutics | TGTX | Maintain | Buy (Buy) |
|
Details | ||
| 1/14/2025 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2024 | Artiva Biotherapeutics | ARTV | New Coverage | Buy (N/A) |
10.64 (5.74) |
-46.05% | Details | |
| 12/24/2024 | Puma Biotechnology | PBYI | Maintain | Buy (Buy) |
|
Details | ||
| 12/23/2024 | Inflarx NV | IFRX | Maintain | Buy (Buy) |
|
Details | ||
| 12/17/2024 | Larimar Therapeutics | LRMR | Maintain | Buy (Buy) |
|
Details | ||
| 11/25/2024 | Longeveron | LGVN | Maintain | Buy (Buy) |
|
Details | ||
| 11/19/2024 | Larimar Therapeutics | LRMR | Maintain | Buy (Buy) |
|
Details | ||
| 11/8/2024 | Valneva SE | VALN | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Inozyme Pharma Inc. | INZY | Maintain | Buy (Buy) |
|
Details | ||
| 10/24/2024 | Avalo Therapeutics Inc. | AVTX | New Coverage | Neutral (N/A) |
11.62 (17.31) |
48.97% | Details | |
| 10/24/2024 | Lumos Pharma | LUMO | Downgrade | Neutral (Buy) |
4.36 (4.34) |
-0.46% | Details | |
| 10/17/2024 | Adicet Bio Inc. | ACET | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/17/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2024 | Dynavax Technologies | DVAX | Maintain | Buy (Buy) |
|
Details | ||
| 10/14/2024 | Nyxoah SA | NYXH | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2024 | Valneva SE | VALN | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2024 | Larimar Therapeutics | LRMR | New Coverage | Buy (N/A) |
6.27 (5.22) |
-16.75% | Details | |
| 10/1/2024 | Adicet Bio Inc. | ACET | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/30/2024 | Lumos Pharma | LUMO | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2024 | Nyxoah SA | NYXH | Maintain | Buy (Buy) |
|
Details | ||
| 9/26/2024 | Inflarx NV | IFRX | Maintain | Buy (Buy) |
|
Details | ||
| 9/25/2024 | Valneva SE | VALN | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2024 | Adicet Bio Inc. | ACET | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/19/2024 | TG Therapeutics | TGTX | Maintain | Buy (Buy) |
|
Details | ||
| 9/18/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (Buy) |
|
Details | ||
| 9/16/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (Buy) |
|
Details | ||
| 9/11/2024 | Adicet Bio Inc. | ACET | Downgrade | Neutral (Buy) |
1.43 (0.75) |
-47.55% | Details | |
| 9/4/2024 | Valneva SE | VALN | Maintain | Buy (Buy) |
|
Details | ||
| 9/4/2024 | Longeveron | LGVN | Maintain | Buy (Buy) |
|
Details | ||
| 8/8/2024 | G1 Therapeutics | GTHX | Downgrade | Neutral (Buy) |
7.06 (7.15) |
1.27% | Details | |
| 7/29/2024 | Longeveron | LGVN | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2024 | Inozyme Pharma Inc. | INZY | Maintain | Buy (Buy) |
|
Details | ||
| 7/2/2024 | Nyxoah SA | NYXH | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2024 | Valneva SE | VALN | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2024 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2024 | Dynavax Technologies | DVAX | Maintain | Buy (Buy) |
|
Details | ||
| 6/25/2024 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2024 | Nyxoah SA | NYXH | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2024 | Bolt Biotherapeutics, Inc. | BOLT | Downgrade | Neutral (Buy) |
1.32 (4.30) |
225.76% | Details | |
| 5/6/2024 | Glycomimetics | GLYC | Downgrade | Neutral (Buy) |
1.83 (0.16) |
-91.26% | Details | |
| 5/3/2024 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2024 | Compugen | CGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2024 | Inozyme Pharma Inc. | INZY | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2024 | SAB Biotherapeutics | SABS | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Nyxoah SA | NYXH | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2024 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2024 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2024 | SAB Biotherapeutics | SABS | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2023 | PaxMedica Inc. | PXMD | New Coverage | Buy (N/A) |
0.90 (0.00) |
-100% | Details | |
| 12/4/2023 | Longeveron | LGVN | New Coverage | Buy (N/A) |
1.97 (0.48) |
-75.63% | Details | |
| 12/4/2023 | Sensei Biotherapeutics | SNSE | New Coverage | Buy (N/A) |
0.69 (0.30) |
-56.52% | Details | |
| 11/15/2023 | SAB Biotherapeutics | SABS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | Valneva SE | VALN | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Inozyme Pharma Inc. | INZY | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2023 | Nyxoah SA | NYXH | New Coverage | Buy (N/A) |
8.02 (3.74) |
-53.37% | Details | |
| 7/27/2023 | Inozyme Pharma Inc. | INZY | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2023 | Valneva SE | VALN | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2023 | Spectrum Pharmaceuticals | SPPI | Downgrade | Neutral (Buy) |
0.92 (1.03) |
11.96% | Details | |
| 4/24/2023 | Inflarx NV | IFRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2023 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2023 | Inflarx NV | IFRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | Magenta Therapeutics | MGTA | New Coverage | Buy (N/A) |
0.81 (0.70) |
-13.58% | Details | |
| 2/24/2023 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2023 | Glycomimetics | GLYC | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2023 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2023 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Inflarx NV | IFRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2022 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2022 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2022 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2022 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2022 | Bolt Biotherapeutics, Inc. | BOLT | New Coverage | Buy (N/A) |
1.51 (4.30) |
184.77% | Details | |
| 10/3/2022 | Valneva SE | VALN | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2022 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2022 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Inflarx NV | IFRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | ChemoCentryx | CCXI | Downgrade | Neutral (Buy) |
50.43 (10.16) |
-79.85% | Details | |
| 8/3/2022 | Glycomimetics | GLYC | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2022 | Valneva SE | VALN | New Coverage | Buy (N/A) |
19.84 (10.52) |
-46.98% | Details | |
| 8/1/2022 | Aileron Therapeutics Inc | ALRN | Downgrade | Neutral (Buy) |
0.19 (2.11) |
1010.53% | Details | |
| 5/17/2022 | Cullinan Management | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2022 | Allena Pharmaceuticals | ALNA | Downgrade | Neutral (Buy) |
0.48 (0.08) |
-83.33% | Details | |
| 2/28/2022 | Celyad SA | CYAD | Downgrade | Neutral (Buy) |
3.22 (0.47) |
-85.4% | Details | |
| 2/7/2022 | Inozyme Pharma Inc. | INZY | New Coverage | Buy (N/A) |
6.10 (4.00) |
-34.43% | Details | |
| 1/24/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2021 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | Lumos Pharma | LUMO | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2021 | ChemoCentryx | CCXI | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2021 | Acceleron Pharma | XLRN | Downgrade | Neutral (Buy) |
175.36 (178.75) |
1.93% | Details | |
| 8/31/2021 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2021 | Cullinan Management | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | Celyad SA | CYAD | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2021 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
13.11 (7.29) |
-44.39% | Details | |
| 4/19/2021 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | ChemoCentryx | CCXI | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2021 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
38.01 (7.47) |
-80.35% | Details | |
| 1/12/2021 | Inflarx NV | IFRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2020 | Curis | CRIS | New Coverage | Buy (N/A) |
1.35 (0.99) |
-26.67% | Details | |
| 11/6/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2020 | ChemoCentryx | CCXI | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2020 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | Lumos Pharma | LUMO | New Coverage | Buy (N/A) |
13.80 (4.34) |
-68.55% | Details | |
| 7/31/2020 | Glycomimetics | GLYC | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2020 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2020 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2020 | Allena Pharmaceuticals | ALNA | New Coverage | Buy (N/A) |
1.68 (0.48) |
-71.43% | Details | |
| 5/12/2020 | ChemoCentryx | CCXI | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2020 | Ideaya Biosciences | IDYA | New Coverage | Buy (N/A) |
3.59 (33.19) |
824.51% | Details | |
| 3/31/2020 | Aileron Therapeutics Inc | ALRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2020 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2020 | Tracon Pharmaceuticals | TCON | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2020 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2020 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2020 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | ChemoCentryx | CCXI | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2020 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2020 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2019 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2019 | Tracon Pharmaceuticals | TCON | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2019 | ArQule | ARQL | Downgrade | Neutral (Buy) |
19.70 (20.00) |
1.52% | Details | |
| 12/6/2019 | Puma Biotechnology | PBYI | New Coverage | Buy (N/A) |
7.44 (6.05) |
-18.68% | Details | |
| 11/26/2019 | ChemoCentryx | CCXI | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2019 | La Jolla Pharma | LJPC | Downgrade | Neutral (Buy) |
2.59 (6.22) |
140.15% | Details | |
| 11/11/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2019 | Dynavax Technologies | DVAX | New Coverage | Buy (N/A) |
4.24 (15.50) |
265.57% | Details | |
| 9/17/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2019 | ArQule | ARQL | New Coverage | Buy (N/A) |
7.97 (19.70) |
147.18% | Details | |
| 8/29/2019 | Tracon Pharmaceuticals | TCON | New Coverage | Buy (N/A) |
0.55 (1.43) |
160% | Details | |
| 8/5/2019 | Glycomimetics | GLYC | Maintain | Buy (N/A) |
|
Details | ||
| 7/5/2019 | Celyad SA | CYAD | Maintain | Buy (N/A) |
|
Details | ||
| 7/5/2019 | Karyopharm Therapeutics | KPTI | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2019 | La Jolla Pharma | LJPC | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2019 | Celyad SA | CYAD | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | Karyopharm Therapeutics | KPTI | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2019 | La Jolla Pharma | LJPC | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2019 | Spectrum Pharmaceuticals | SPPI | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2019 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2018 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details |
